[Comment] Refining COVID-19 care for immunocompromised patients

Since 2022, with the emergence of highly transmissible omicron variants and the relaxation of social distancing measures, protecting individuals who are immunocompromised from SARS-CoV-2 exposure has become increasingly difficult. As a result, these patients have been more frequently reported to have severe and persistent COVID-19.1,2 Currently, most COVID-19-related consultations performed by infectious diseases' doctors concern managing COVID-19 in patients who are immunocompromised.